rs2015767993
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_031961.3(KRTAP9-2):c.116A>G(p.Gln39Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_031961.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.00  AC: 0AN: 152150Hom.:  0  Cov.: 34 
GnomAD4 exome Cov.: 187 
GnomAD4 genome  Data not reliable, filtered out with message: AC0 AF:  0.00  AC: 0AN: 152150Hom.:  0  Cov.: 34 AF XY:  0.00  AC XY: 0AN XY: 74324 
ClinVar
Submissions by phenotype
not specified    Uncertain:1 
The c.116A>G (p.Q39R) alteration is located in exon 1 (coding exon 1) of the KRTAP9-2 gene. This alteration results from a A to G substitution at nucleotide position 116, causing the glutamine (Q) at amino acid position 39 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at